A low-cost optical biosensing platform that detects endotoxins in continuous flow without traditional reagents, using functionalized gold nanoparticles and an LED-LDR optical setup. Designed for real-time monitoring in biological and pharmaceutical systems with a limit of detection of 0.05 EU/ml.
This solution offers an automated, reagent-free method for detecting endotoxin in continuous flow environments. Endotoxins, which are fragments of gram-negative bacteria, can trigger severe inflammatory responses in humans and are a critical concern in pharmaceutical manufacturing, water quality monitoring, medical device safety, and biomedical research. Current detection methods rely on the Limulus Amebocyte Lysate (LAL) assay, which is sensitive to environmental fluctuations such as pH, temperature, and pyrogens, and can produce false positives from carbohydrate-like molecules.
The proposed system uses LPS binding proteins (LPB) functionalized onto gold nanoparticles (AuNPs). When endotoxin is present, it binds specifically to LPB on multiple sides of the nanoparticles, causing aggregation. This aggregation is detected optically as a measurable decrease in light intensity transmitted through the nanoparticle solution, with intensity shift proportional to endotoxin concentration.
Key features:
The technology is at an early-to-mid development stage. The biological basis for endotoxin binding with LPB has been well established in prior literature, and the proposed functionalization approach using EDC-NHS coupling is a standard chemistry method. Next steps include preparing and characterizing AuNPs, functionalizing them with LPB, procuring LED and LDR components, and assembling an Arduino-controlled continuous flow system with calibrated sensor response across varying endotoxin concentrations. The platform will then be packaged for integration with existing biological monitoring infrastructure.
Iowa State University is a large, comprehensive public land‑grant research university based in Ames, known for combining fundamental discovery with translational, industry‑relevant work. Companies collaborate through a research and technology park that co‑locates corporate R&D with faculty labs and startups, creating steady talent pipelines. Pilot‑scale facilities, field test sites, and a statewide extension network support prototyping, validation, and deployment with partners across the region. Research is supported by competitive federal funding, including awards from NSF, USDA, and DOE. A dedicated technology transfer office and affiliated research foundation streamline IP, licensing, and startup formation, with incubator space on site.